Video

Data

Text duration start ents sentiment
of its protein-based vaccine and 10 new 4.96 Jump to 16.88
    CARDINAL 10
uh shipped our first product to uh 4.479 Jump to 64.96
first product to indonesia we shipped 10 4.161 Jump to 69.439
    ORDINAL first
    CARDINAL 10
million doses we focused on low and 5.36 Jump to 71.36
middle income countries first and uh we 4.8 Jump to 73.6
    ORDINAL first
have to balance in this first quarter as 4.0 Jump to 87.04
    DATE this first quarter
uh rocky at first but it's going great 5.12 Jump to 99.52
    ORDINAL first
billion doses this year so we're at a 5.84 Jump to 143.84
    DATE this year
over 200 million doses per month by the 4.24 Jump to 149.68
market for primary vaccination two-dose 3.92 Jump to 158.56
    CARDINAL two
about as three-dose vaccination 5.44 Jump to 162.48
    CARDINAL three
is unsatisfied they're 30 to 40 5.84 Jump to 164.72
    CARDINAL 30 to 40
in high-income countries there are 30 5.039 Jump to 167.92
    CARDINAL 30
you're talking about a third dose and 4.08 Jump to 176.879
    ORDINAL third
perhaps a fourth dose boosting you know 4.16 Jump to 178.56
    ORDINAL fourth
90 percent of the world's population 3.36 Jump to 180.959
    PERCENT 90 percent
you do consider the three doses fully 4.56 Jump to 195.2
    CARDINAL three
one of the things that we've seen other 4.0 Jump to 198.0
    CARDINAL one
billion doses of vaccine distributed 3.839 Jump to 222.48
to our advantage one is that it's it's 4.961 Jump to 243.439
number two it's stable we've got a 3.6 Jump to 248.4
    CARDINAL number two
of nine months instead of six months uh 4.239 Jump to 252.0
    DATE nine months
    DATE six months
roles that now each one of these vaccine 3.76 Jump to 278.24
vaccine company one after another hit 5.76 Jump to 353.36
think about one is tolerability uh how 4.32 Jump to 378.8
well first of all i think you should 3.359 Jump to 475.28
    ORDINAL first
going on that we started six months ago 4.72 Jump to 502.8
    DATE six months ago